Edesa Biotech Inc
NASDAQ:EDSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edesa Biotech Inc
NASDAQ:EDSA
|
CA |
|
Abercrombie & Fitch Co
NYSE:ANF
|
US |
Intrinsic Value
The intrinsic value of Edesa Biotech Inc (EDSA) under the Base Case is 0.64 USD per share.
Compared with the current market price of 2.77 USD, the stock appears
Overvalued by 77% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Edesa Biotech Does
Edesa Biotech is a clinical-stage drug developer. It does not sell consumer products or run a drugstore business; instead, it develops prescription medicines aimed at inflammatory and immune-related diseases, especially conditions where the body’s own immune response drives damage. The company’s work centers on moving these drug candidates through laboratory and clinical testing and, if they succeed, turning them into approved treatments.
- Headquarters
- Canada CA
- Employees
- 17
- IPO date
- Aug 25, 2008
Revenue & Expenses Breakdown
Edesa Biotech Inc
Earnings Waterfall
Edesa Biotech Inc
The intrinsic value for Edesa Biotech Inc (EDSA) under the Base Case is 0.64 USD.
Compared with the current market price of 2.77 USD, the stock appears Overvalued by 77% .